Global Mesalamine Market Analysis by Grade, Form (Tablet, Granule etc.,) Application (Pharmaceutical & Colorant) Global Opportunity, Share, Trends, Challenges Analysis & Industry Forecast (2018-2023)

May 2018 | 105 pages | ID: GDCE243A08FEN
SPER Market Research

Abstracts

REPORT DESCRIPTION

This report represents the global and regional analysis of Mesalamine in terms of Dosage, Strength, API, application (Pharmaceutical & Colorant) Wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent Wise (North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa) manufacturer & buyers also.

Mesalamine Introduction

“Mesalamine” is odorless white to pinkish crystals or purplish-tan powder which is used as anti-inflammatory agent, by the production of prostaglandin & inhibition of cyclooxygenase. Most commonly it is consumed through oral administration. It is freely soluble with hot water & slightly soluble with water or alcohol. It is available in different forms including tablet, capsules & liquid. It is also used in dye or colorant industry in the manufacturing of azo & Sulphur dyes. It also functions as an intermediate of various pharmaceutical products.

REPORT HIGHLIGHTS

• Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2023.
• Provide complete overview including type, application & forecast region.
• Provide complete analysis of API & formulation including brand names, strength & market overview.
• Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
• Historical, current and projected market size in terms of volume and value.
• Analyze the global & regional potential market, advantages, risk & opportunity.
• Identify significant trends and factors driving or inhibiting the market growth.
• In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.

The report covers Application analysis on;

• Mesalamine In Pharmaceutical Industry
• Mesalamine In Dye or Colorant Industry

The report covers exhaustive analysis on;

• Market Segments
• Market Dynamics
• Brands In Market
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved
• Forecasting
• Technology

The report includes Regional analysis on;

• North America (U.S., Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA)

Top Players in Mesalamine industry

• Perrigo Israel Pharmaceuticals Ltd
• Sun Pharmaceutical India Ltd
• Cadila Healthcare Ltd
• SG Pharma Pvt Ltd
• Vitas-M Laboratory
• MP Biomedicals
• Gavis Pharmaceutical
• Allergan Pharmaceuticals International Ltd
• G And W Laboratories Inc
• Meda Pharmaceuticals Inc

Key Questions answered by report

• What was the market size trend of 2015-2017?
• What will be the market size trend of next 4-5 years?
• What are the most common brands in terms of volume?
• How much brands available for Mesalamine?
• Who are the key players of Mesalamine API?
• What are the major application industries & emerging industries?
• Who are the key vendors present in the market?
• How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
• Which one segment from global coverage will be lucrative & will grow?
• What are the main market opportunities and threats faced by the vendors?
• What are the strategies are following by the existing market players?

Contents

CHAPTER 1 RESEARCH METHODOLOGY

CHAPTER 2 REPORT DESCRIPTION

CHAPTER 3 MESALAMINE EXECUTIVE SUMMARY

CHAPTER 4 MESALAMINE BASIC HIGHLIGHTS

4.1. Product Overview
4.2. CAS No & Molecular Weight
4.3. Innovator Details
4.4. Priority & Patent Expiry
4.5. Molecular Formula
4.6. Market Status

CHAPTER 5 GLOBAL MESALAMINE PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY

5.1. Mesalamine Forms
  5.1.1. Mesalamine In Table t Form
  5.1.2. Mesalamine In Oral Solution Form
5.2. Mesalamine Grades Description
5.3. Mesalamine Synonyms
5.4. Mesalamine Application Industry
  5.4.1. Mesalamine In Pharmaceutical Industry
  5.4.2. Mesalamine In Colorant Industry

CHAPTER 6 MESALAMINE MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM

6.1. Mesalamine Manufacturing Process Routes & Flow Chart
6.2. Mesalamine Upstream & Downstream Products

CHAPTER 7 MESALAMINE BRAND LIST & MECHANISM OF ACTION

7.1. Mesalamine All Global Brands
7.2. Mesalamine Dosage & Their Strengths
7.3. Mesalamine Mechanism of Action

CHAPTER 8 MESALAMINE (FORMULATION) REGION WISE MARKET OVERVIEW

8.1. Mesalamine Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
8.2. Mesalamine Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
8.3. Mesalamine Market Overview In North America (Canada, US & Rest of North America Available)
8.4. Mesalamine Market Overview In South America (Brazil, Argentina & Rest of South America Available)
8.5. Mesalamine Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 9 MESALAMINE (API) REGION WISE MARKET OVERVIEW

9.1. Mesalamine Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
9.2. Mesalamine Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
9.3. Mesalamine Market Overview In North America (Canada, US & Rest of North America Available)
9.4. Mesalamine Market Overview In South America (Brazil, Argentina & Rest of South America Available)
9.5. Mesalamine Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)

CHAPTER 10 MESALAMINE (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW

10.1. Mesalamine Continent Wise Manufacturers
10.2. Mesalamine Continent Wise Manufacturing Volume
10.3. Mesalamine Country Wise Manufacturers
10.4. Mesalamine Country Wise Manufacturing Volume
10.5. Mesalamine Manufacturers Contact Overview

CHAPTER 11 MESALAMINE GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS

11.1. Mesalamine Global Price Trend Analysis
11.2. Mesalamine Country Wise Price Trend Analysis

CHAPTER 12 MESALAMINE INTERNATIONAL MARKET OVERVIEW

12.1. Global Demand/ Supply & Global Prices
12.2. Major Destinations Involved In Trade
12.3. Major Manufacturers (Capacities & Prices)

CHAPTER 13 MESALAMINE (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2018-2023) ANALYSIS

13.1. Mesalamine Global Market Size (Past & Future Forecasting)
13.2. Mesalamine Global Market Growth (Past & Future Forecasting)
13.3. Mesalamine Continent Wise Market Size (Past & Future Forecasting)
13.4. Mesalamine Continent Wise Market Growth (Past & Future Forecasting)

CHAPTER 14 MESALAMINE (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW

14.1. Mesalamine Global Consumers
14.2. Mesalamine Global Consumers As Per Consumption Quantity
14.3. Mesalamine Continent Wise Consumer
14.4. Mesalamine Continent Wise Consumer As Per Consumption Quantity
14.5. Mesalamine Country Wise Consumer
14.6. Mesalamine Country Wise Consumer As Per Consumption Quantity
14.7. Mesalamine Consumers Contact Overview

CHAPTER 15 MESALAMINE CONTINENT WISE EXPORT/ IMPORT ANALYSIS

15.1. Mesalamine Continent Wise Import Analysis
15.2. Mesalamine Continent Wise Export Analysis
15.3. Mesalamine Country Wise Import Analysis
15.4. Mesalamine Country Wise Export Analysis

CHAPTER 16 MESALAMINE WORLDWIDE SWOT ANALYSIS

16.1. Mesalamine Strength Analysis
16.2. Mesalamine Weakness Analysis
16.3. Mesalamine Opportunity Analysis
16.4. Mesalamine Threat Analysis

CHAPTER 17 MESALAMINE REPORT BASED BUSINESS RECOMMENDATION